German Healthcare Services Stock News

Ströer SE KGaA (XTRA:SAX) has wrapped up FY 2025 with fourth quarter revenue of €603.3 million and net income of €65 million, setting the tone for how investors read the year as a whole. Over recent quarters the company has seen revenue move from €475.5 million in Q1 2025 to €504.7 million in Q2 and €491.5 million in Q3. Trailing twelve month revenue sits at about €2.1 billion and net income at €140 million, giving helpful context around the most recent print. With net profit margin at 6.7%...

Mercedes-Benz Group (XTRA:MBG) FY 2025 earnings snapshot Mercedes-Benz Group (XTRA:MBG) has wrapped up FY 2025 with fourth quarter revenue of €33.7b and basic EPS of €1.43, backed by net income of €1.4b. The company has seen quarterly revenue move from €38.5b and EPS of €2.57 in Q4 2024 to €33.7b and €1.43 in Q4 2025, with FY 2025 quarters ranging between €32.1b and €33.7b of revenue and EPS between €0.95 and €1.74. With trailing net margin sitting at 3.9% versus 7% a year earlier, this set...

Bayer FY 2025 earnings snapshot Bayer (XTRA:BAYN) has capped FY 2025 with a tough final quarter, posting Q4 revenue of €11.4 billion and a basic EPS loss of €3.80, alongside a net loss of €3.8 billion. Over recent periods, the company has seen quarterly revenue move between €9.7 billion and €13.7 billion, while EPS has swung from a profit of €1.32 in Q1 2025 to losses in each of the following quarters. This keeps the focus firmly on how quickly margins can stabilize. With forecasts in the...

Symrise (XTRA:SY1) shares are in focus after the company paired its 2025 results with a proposed dividend increase, a new Care & Wellness division, and a €400 million share buyback program. See our latest analysis for Symrise. At a share price of €72.68, Symrise has a 1-day share price return of 2.45% and a year to date share price return of 6.32%. However, the 1-year total shareholder return of 23.13% and 5-year total shareholder return of 24.66% show that longer term holders have faced...

Sixt (XTRA:SIX2) has moved into focus after reporting 2025 earnings, with sales of €4,282.98m and net income of €285.81m, alongside a proposed 18.5% dividend increase. See our latest analysis for Sixt. The 1-day share price return of 4.34% to €67.25 comes after record 2025 results. However, the 1-year total shareholder return of a 21.46% decline and the 3-year total shareholder return of a 39.08% decline suggest momentum has been fading despite recent earnings strength. If this earnings news...

LEG Immobilien (XTRA:LEG) has wrapped up FY 2025 with Q4 revenue of €397.3 million and basic EPS of €4.37, while its trailing twelve month figures sit at €1.58 billion of revenue and EPS of €19.44. Over recent periods, revenue has moved from €515.6 million in Q4 2024 to €468.7 million in Q1 2025, €361.7 million in Q2, €351.4 million in Q3 and €397.3 million in Q4, with quarterly EPS ranging from €0.77 to €9.08. As a result, investors are likely to focus on how these swings and the very high...

Hensoldt (XTRA:HAG) is back in focus after raising its 2026 earnings guidance, with the company now targeting around €2,750 million in revenue, along with a higher annual dividend proposal and renewed leadership commitment. See our latest analysis for Hensoldt. Despite the raised 2026 guidance and higher dividend proposal, Hensoldt’s recent news flow has coincided with pressure on the share price. A 1 month share price return of 10.69% and a 7 day share price return of 6.26% indicate that...

Why Lufthansa is suddenly back in focus Deutsche Lufthansa (XTRA:LHA) is back on many watchlists after Middle East tensions disrupted key air corridors, pushed fuel costs higher, and coincided with labor disputes and an earnings update scheduled for March 6, 2026. See our latest analysis for Deutsche Lufthansa. At a latest share price of €8.402, Deutsche Lufthansa has seen short term pressure, with a 7 day share price return of an 8.51% decline and a 30 day share price return of a 5.85%...

If you are wondering whether adidas shares are starting to look interesting or still too expensive, you are not alone. Many investors are asking what the current price really reflects about the business. The stock closed at €141.80, with a 10.5% decline over 7 days, a 5.6% decline over 30 days, a 15.3% decline year to date, a 39.9% decline over 1 year and a 48.9% decline over 5 years. This naturally raises questions about how expectations and risk are being priced in. Recent coverage around...

Fresenius SE KGaA (XTRA:FRE) is back in focus after reporting fourth quarter 2025 results, proposing a €1.05 dividend per share and outlining board changes alongside management’s comments on geopolitical and supply chain pressures. See our latest analysis for Fresenius SE KGaA. Even with the earnings beat, higher proposed dividend and board changes, the share price has slipped over the past week, with a 7 day share price return of 4.27%. However, a 1 year total shareholder return of 25.23%...

BASF (XTRA:BAS) has been highlighted as a key player in the ammonium sulfate market. A recent industry report points to projected growth in ammonium sulfate demand across fertilizers, food processing, and emissions control. The company is positioned among top global suppliers, which may create additional opportunities for business expansion. BASF is a global chemicals group with exposure to agricultural inputs and industrial applications where ammonium sulfate plays an important role. The...

Wondering whether SAP at €165.48 is starting to look attractive or still expensive compared to its fundamentals? This article is designed to help you put a clear value range around the stock. The share price has had a mixed run, with a 0.2% decline over the last 7 days and a 3.0% decline over 30 days, while year to date it is down 18.1% and 35.5% lower over 1 year. It is still up 55.2% over 3 years and 69.5% over 5 years. Recent headlines around SAP have focused on broader sector sentiment,...

Why Fresenius Medical Care is back on investors’ radar Fresenius Medical Care (XTRA:FME) has just packed several key updates into its 2025 results, including a sharp rise in net income, higher earnings per share, new 2026 guidance, a higher proposed dividend, and completion of a sizeable buyback. See our latest analysis for Fresenius Medical Care. These 2025 results, new 2026 guidance and the completed buyback come after a mixed stretch for the stock, with a 30 day share price return of 4.22%...

Why TUI’s post earnings drop is attracting attention TUI (XTRA:TUI1) shares fell sharply after hours on 2 March 2026 following recent earnings, as mixed sentiment and a shift away from travel stocks put fresh focus on the group’s fundamentals. Investors now appear to be tracking airline capacity, holiday bookings and fuel costs more closely. The next earnings update on 13 May 2026 is likely to offer further detail on operating income and near term cash generation. See our latest analysis for...

European defense stocks moved higher after U.S. and Israeli strikes on Iran and subsequent retaliation, and Rheinmetall (XTRA:RHM) is among the names catching investor attention as missile and air-defense exposure returns to focus. See our latest analysis for Rheinmetall. Beyond the latest jump in defense interest, Rheinmetall’s share price has pulled back recently, with a 1 month share price return of an 11% decline and a 7 day share price return of an 8.38% decline. However, its 1 year...

Bank of America Corporation has disclosed that its total voting rights in Mercedes-Benz Group AG have risen above the 5% threshold. The crossing of this regulatory threshold was reported under European securities rules and marks a material change in a major financial institution’s position. For you as an investor looking at XTRA:MBG, this stake change comes against a mixed share price record. The stock is at €55.76, with a 1 year return of 4.8% and a 5 year return of 28.9%, while the year...

If you are wondering whether Münchener Rückversicherungs-Gesellschaft in München is offering fair value at current levels, starting with a clear view of its valuation can help you frame your next move. The share price recently closed at €551.80, with returns of 1.7% over the last 7 days, 7.7% over the last 30 days, 2.1% year to date, 1.6% over 1 year, 85.0% over 3 years and 151.7% over 5 years. This gives useful context before comparing price to fundamentals. Recent news around large...

Hensoldt AG recently reported its 2025 results, with sales rising to €2,455 million from €2,240 million, while net income eased to €89 million from €108 million. Alongside extending CEO Oliver Dörre’s contract to 2031, Hensoldt booked a record €4.71 billion order intake for 2025 and raised its 2026 guidance, underscoring strong demand for its defense sensor technologies. Next, we’ll examine how this record order intake and raised 2026 guidance may reshape Hensoldt’s investment narrative and...

AlzChem Group (XTRA:ACT) has drawn fresh attention after reporting full year 2025 results along with an annual dividend of €2.10 per share, with payment scheduled for May 8, 2026, following early May key dates. See our latest analysis for AlzChem Group. The latest earnings and dividend news comes after a strong run, with the 90 day share price return of 19.63% and a very large 3 year total shareholder return. This suggests that momentum has recently been building. If AlzChem’s move has you...

Why thyssenkrupp is on investors’ radar today thyssenkrupp (XTRA:TKA) is back in focus after recent share price moves, with the stock showing mixed short term returns and a stronger picture over the past year and past 3 months. For investors, that uneven performance, combined with fresh financial data, raises questions about how the company’s current valuation lines up against its earnings profile, balance of segments, and long operating history. See our latest analysis for...

Why ZEISS Collaborative Care matters for Carl Zeiss Meditec shareholders Carl Zeiss Meditec (XTRA:AFX) has introduced ZEISS Collaborative Care, a browser-based tool for secure data sharing and referrals between eye care providers. This launch underscores the group’s push into connected digital workflows in ophthalmology. See our latest analysis for Carl Zeiss Meditec. Despite the ZEISS Collaborative Care announcement, Carl Zeiss Meditec’s recent trading has been weak. The company has reported...

Daimler Truck Holding (XTRA:DTG) is seeing tougher competition as more manufacturers push into electric commercial vehicles. The shift is being driven by lower battery costs and tighter emission rules that are accelerating adoption of electric trucks. Rivals are also investing in battery technology and energy services, raising the bar for Daimler Truck across key product segments. Daimler Truck, a major player in heavy duty and commercial vehicles, is now operating in a market where...

Adidas, ticker XTRA:ADS, has expanded its NCAA baseball relationship with New Era to outfit all Power Four conference partner schools with co branded on field caps. The move extends Adidas branded visibility across high profile college baseball programs through New Era's established headwear platform. For you as an investor looking at XTRA:ADS, this fits into the company’s focus on performance sports and branded merchandise tied to major leagues and college programs. College baseball sits...

Deutsche Telekom (XTRA:DTE) agrees a partnership with Starlink to roll out satellite based mobile connectivity across Europe, enabling direct to device service for users in remote or hard to reach areas. The company expands its alliances with Nokia and Capgemini to advance AI native and open RAN technologies across its radio access networks. Together, these moves aim to broaden coverage, increase network resilience during infrastructure stress, and support more programmable mobile...